# Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Diagnosed AML

> clinical trial · VERIFIED · 2026-09-02

Status: ACTIVE_NOT_RECRUITING · Sponsor: West Virginia University · Condition: Acute Myeloid Leukemia

- Company: West Virginia University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04953780

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.